Consistent signatures in the human gut microbiome of old- and young-onset colorectal cancer
Open Access
- 22 April 2024
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-13
Abstract
The incidence of young-onset colorectal cancer (yCRC) has been increasing in recent decades, but little is known about the gut microbiome of these patients. Most studies have focused on old-onset CRC (oCRC), and it remains unclear whether CRC signatures derived from old patients are valid in young patients. To address this, we assembled the largest yCRC gut metagenomes to date from two independent cohorts and found that the CRC microbiome had limited association with age across adulthood. Differential analysis revealed that well-known CRC-associated taxa, such as Clostridium symbiosum, Peptostreptococcus stomatis, Parvimonas micra and Hungatella hathewayi were significantly enriched (false discovery rate Fusobacterium nucleatum, Bacteroides fragilis and Escherichia coli were observed for oCRC and yCRC. Almost all oCRC-associated metagenomic pathways had directionally concordant changes in young patients. Importantly, CRC-associated virulence factors (fadA, bft) were enriched in both oCRC and yCRC compared to their respective controls. Moreover, the microbiome-based classification model had similar predication accuracy for CRC status in old- and young-onset patients, underscoring the consistency of microbial signatures across different age groups.Keywords
All Related Versions
This publication has 67 references indexed in Scilit:
- Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancerCell Host & Microbe, 2023
- Enrichment of oral-derived bacteria in inflamed colorectal tumors and distinct associations of Fusobacterium in the mesenchymal subtypeCell Reports Medicine, 2023
- The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detectionThe Lancet Gastroenterology & Hepatology, 2022
- Screening for Colorectal CancerJAMA, 2021
- Microbiome in Colorectal Cancer: How to Get from Meta-omics to Mechanism?Trends in Microbiology, 2020
- Fecal Clostridium symbiosum for Noninvasive Detection of Early and Advanced Colorectal Cancer: Test and Validation StudiesEBioMedicine, 2017
- Age-Related Changes in the Composition of Gut Bifidobacterium SpeciesCurrent Microbiology, 2017
- MEGAHIT v1.0: A fast and scalable metagenome assembler driven by advanced methodologies and community practicesMethods, 2016
- HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR, FOCUS and PICCOLO colorectal cancer trialsThe Journal of Pathology, 2015
- Fusobacterium nucleatum Promotes Colorectal Carcinogenesis by Modulating E-Cadherin/β-Catenin Signaling via its FadA AdhesinCell Host & Microbe, 2013